In modern clinical practice, the vast majority of patient needs are met effectively by mass-manufactured, TGA-registered medicines. These standardised pharmaceuticals are the backbone of our healthcare system, providing safety, efficacy, and consistency for the general population. However, every practitioner encounters the “outliers”—patients for whom standard dosages, dosage forms, or commercial formulations simply do not work.
Whether it is a paediatric patient requiring a micro-dose not available in tablet form, a geriatric patient with dysphagia unable to swallow large capsules, or a veterinary case requiring a transdermal solution for a fractious cat, the “one-size-fits-all” model has limitations.
This is where pharmaceutical compounding becomes a critical adjunctive tool. It is not a replacement for standard care, but rather a problem-solving mechanism for specific clinical challenges. This guide is designed for medical practitioners, veterinarians, and dentists to outline when compounded alternatives may be appropriate, the regulatory landscape in Australia, and how to collaborate effectively with a compounding pharmacist to ensure patient safety.
What Is Pharmaceutical Compounding? (Clinical Overview)
At its core, pharmaceutical compounding is the extemporaneous preparation of a medicinal product to meet the specific needs of an individual patient. Unlike manufacturing, which involves large-scale production of standardised units for general distribution, compounding is a reactive process triggered by a practitioner’s prescription for a specific patient.
It represents the traditional roots of pharmacy practice—mixing raw ingredients to create a therapeutic product. However, modern compounding has evolved significantly. Today, it involves sophisticated equipment, strict quality assurance processes, and access to high-grade Active Pharmaceutical Ingredients (APIs).
It is crucial to distinguish compounding from manufacturing. Compounded medicines are exempt from entry in the Australian Register of Therapeutic Goods (ARTG) because they are prepared for a specific individual. This means they have not undergone the rigorous evaluation for safety, quality, and efficacy that registered medicines have. Therefore, they should only be prescribed when a suitable ARTG product is unavailable or unsuitable.
At Compounding Chemist, we have been supporting prescribers with this precise service since 1998. We act as a bridge, facilitating treatment when the commercial market cannot supply what your patient requires.
Common Clinical Scenarios Where Compounded Alternatives May Be Considered
The decision to prescribe a compounded medicine should always be driven by a specific clinical need that cannot be met by a commercial product. The following scenarios represent common justifications for considering a compounded alternative.
Unavailable Commercial Strengths
Commercial manufacturing relies on economic viability, which often results in a limited range of available strengths. In mental health, pain management, and paediatrics, patients often require titration schedules that do not align with manufactured tablets. Compounding allows for:
- Micro-dosing: Creating strengths significantly lower than the lowest commercial dose (e.g., for paediatric cardiology or weaning off antidepressants).
- Intermediate dosing: Filling the gap between standard increments (e.g., if 50mg is ineffective but 100mg causes adverse effects).
Excipient Intolerance or Allergy
Commercial tablets and syrups contain numerous excipients—binders, fillers, preservatives, and dyes. For a patient with Coeliac disease, severe lactose intolerance, or specific chemical sensitivities, the inactive ingredients in a standard medication can trigger adverse reactions that compromise adherence or health. A compounding pharmacist can reformulate the active ingredient using a hypoallergenic base, such as a cellulose filler, removing the problematic excipient entirely.
Palatability and Administration Challenges
Medication adherence is often compromised by the physical form of the drug. This is particularly prevalent in:
- Paediatrics: Children may refuse bitter-tasting tablets or liquids. Compounding allows for the alteration of flavour profiles (e.g., strawberry, bubblegum) to improve compliance.
- Geriatrics: Patients with dysphagia may require a medication converted from a solid dosage form into a suspension or a troche (a lozenge that dissolves in the mouth).
- Veterinary Medicine: Administering oral tablets to animals can be physically difficult and stressful for the owner. Converting a medication into a flavoured chew or a transdermal gel (applied to the inner ear) can significantly improve treatment outcomes.
Supply Shortages and Discontinued Lines
Drug shortages are an increasing reality in the Australian healthcare landscape. When a critical medication is temporarily unavailable or permanently discontinued by the manufacturer for commercial reasons, compounding can ensure continuity of care. Provided the raw API is available, a compounding pharmacy can replicate the strength and form of the unavailable drug.
Key Clinical Considerations Before Prescribing Compounded Alternatives
Prescribing a compounded medicine requires a different risk assessment framework compared to prescribing a registered medicine. Because these products are not TGA-assessed, the onus of clinical justification weighs heavier on the prescriber.
Evidence Base and Therapeutic Rationale
Before writing a script, consider the evidence supporting the transdermal or oral use of the specific active ingredient in the proposed form. Not all drugs are stable in liquid form, and not all drugs cross the transdermal barrier effectively. The therapeutic rationale must be sound. If you are unsure about the bioavailability of a specific formulation, this is the moment to consult with a compounding pharmacist.
Patient Suitability and Informed Consent
Patients must be informed that the medication you are prescribing is an “unapproved” therapeutic good. This does not mean it is unsafe, but rather that it has not been evaluated by the TGA. Informed consent is vital. Patients should understand:
- Why this specific formulation is necessary.
- That consistency may vary slightly between batches compared to mass-manufactured pills.
- The importance of adhering to storage instructions and expiry dates.
Monitoring and Review
Given the personalised nature of these medicines, standard monitoring protocols may need adjustment. For example, if switching a patient from an oral tablet to a transdermal cream for hormone therapy or pain management, blood levels or clinical response should be monitored closely during the transition to ensure therapeutic targets are met.
Regulatory and Professional Responsibilities (Australia Context)
In Australia, the compounding of medicines is strictly regulated to ensure public safety. Recent guidelines from the Pharmacy Board of Australia and the TGA (updated October 2024) have reinforced the responsibilities of both pharmacists and prescribers.
The “Cascade” of Prescribing
Regulatory bodies generally expect a “cascade” approach to prescribing:
- First Line: Use a suitable TGA-registered medicine.
- Second Line: Use an off-label TGA-registered medicine (if clinical evidence supports it).
- Third Line: Consider a compounded alternative only if the above are unsuitable or unavailable.
Prescription-Only Requirements
Compounded medicines for therapeutic use must be supplied on the basis of a prescription for a specific patient. “For Office Use” or bulk supply to a clinic is generally prohibited under TGA exemptions, except in very specific circumstances. This ensures that a clinical relationship exists between the prescriber, the patient, and the pharmacist.
Documentation
It is good practice to document the clinical justification for the compounded medicine in the patient’s notes. Phrases such as “Commercial product unsuitable due to [specific reason]” or “Patient requires dosage form not commercially available” demonstrate that you have considered the regulatory hierarchy.
Working Collaboratively With a Compounding Pharmacist
The most successful compounded therapies result from a collaborative relationship between the prescriber and the pharmacist. Pharmacists are the experts in formulation science, stability, and physical chemistry.
Determining Feasibility
Before promising a patient a specific solution (e.g., “We can turn these tablets into a cream”), it is advisable to contact the compounding pharmacist. We can verify:
- Solubility: Can this drug be dissolved in the requested volume?
- Stability: Will the drug degrade rapidly in a liquid or cream base?
- Absorption: Is the molecular size of the drug small enough to penetrate the skin?
Defining Formulation Requirements
A prescription for a compounded medicine requires more detail than a standard script. To avoid delays, ensure your prescription includes:
- Active Ingredient: Generic name.
- Strength: Explicitly stated (e.g., mg/mL for liquids, % for creams).
- Dosage Form: (e.g., Capsule, Suspension, Troche).
- Quantity: Total amount (e.g., 100 capsules, 50g cream).
- Directions for Use: Clear and unambiguous.
The Role of Feedback
Feedback loops are essential. If a patient reports that a transdermal gel is irritating their skin, or a flavoured suspension is still too bitter, let the pharmacist know. We can often adjust the base or the flavour profile in the next batch to improve tolerability.
Managing Expectations and Patient Communication
Setting realistic expectations is key to patient satisfaction with compounded alternatives. Because these medicines are made from scratch, the logistics differ from standard pharmacy visits.
Timeline for Preparation
Patients should be advised that their medication will not be ready immediately. Unlike dispensing a box from a shelf, compounding involves weighing, mixing, quality checking, and packaging. A turnaround time of 24 to 48 hours is standard.
Expiry and Storage
Compounded medicines typically have shorter expiry dates than commercial products because they do not contain the heavy-duty preservatives used in mass manufacturing. A liquid suspension might have a shelf life of 30 days; a capsule might last 6 months. It is crucial to remind patients not to hoard these medications and to respect the “Do Not Use After” date.
Cost Considerations
Compounded medications are generally private prescriptions and are rarely covered by the Pharmaceutical Benefits Scheme (PBS). While some private health funds offer rebates, patients should be prepared for the cost structure, which reflects the labour and expertise involved in manual preparation.
Frequently Asked Questions
When should a prescriber consider compounded alternatives?
A prescriber should consider a compounded alternative only when a TGA-registered commercial product is unavailable, unsuitable (e.g., due to allergy), or does not exist in the required strength or dosage form. It should be driven by a specific clinical need.
Are compounded medicines regulated in Australia?
Yes. While the medicines themselves are exempt from ARTG listing, the practice of compounding is regulated by the Pharmacy Board of Australia and the TGA. Compounding pharmacies must adhere to strict professional standards regarding facility quality, ingredient sourcing, and training.
What information must be on a compounded prescription?
The prescription must include the patient’s details, the prescriber’s details, the active ingredient, the specific strength (mg or %), the dosage form (capsule, cream, etc.), the quantity, and clear directions for use. Noting the reason for compounding (e.g., “Lactose Free”) helps the pharmacist ensure the formulation meets the clinical need.
How should patients be counselled about compounded medicines?
Patients should be informed that the medicine is made specifically for them and has not been evaluated by the TGA. They should be counselled on specific storage requirements (e.g., refrigeration), the importance of measuring liquid doses accurately, and strictly adhering to the expiry date.
How can prescribers work effectively with compounding pharmacists?
Open communication is the best strategy. Call or email the pharmacist to discuss complex cases before prescribing. This allows the pharmacist to advise on formulation stability, base selection, and feasibility, ensuring the patient receives a safe and effective product.
Supporting Individualised Prescribing Decisions
Pharmaceutical compounding remains a vital, specialised area of medical practice. It provides a safety net for patients who fall outside the standard treatment protocols and ensures that clinical care is not dictated solely by commercial availability.
However, it requires a thoughtful, risk-based approach. By understanding the regulatory framework and collaborating closely with experienced pharmacists, practitioners can utilise compounding to deliver truly personalised healthcare.
If you have a patient with complex needs or require advice on a specific formulation, we invite you to reach out to our team. At Compounding Chemist, we have been partnering with Australian practitioners since 1998 to solve medication challenges with precision and care.
